Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Protagonist Therapeutics, Inc (PTGX)
|
Add to portfolio |
|
|
|
| Price: |
$25.57
| | Metrics |
| OS: |
51.3
|
M
| |
-64
|
% ROE
|
| Market cap: |
$1.31
|
B
| |
-151
|
% ROIC
|
|
Net cash:
|
$237
|
M
| |
$4.63
|
per share
|
|
EV:
|
$1.07
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($147)
|
M
| |
|
|
| EPS |
($2.68)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | 0.0 | 0.0 |
| Revenue growth | -2.8% | -4.4% | 12293.1% | -99.3% | 54.1% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 26.6 | 27.4 | 28.6 | 0.2 | 30.9 | 20.1 | 0.0 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | |
| Research and development | 126.2 | 126.0 | 74.5 | 65.0 | 59.5 | 46.2 | 25.7 | 11.8 |
| General and administrative | 31.7 | 27.2 | 18.6 | 15.7 | 13.7 | 11.8 | 7.0 | 3.0 |
| EBIT | -131.4 | -125.8 | -64.5 | -80.5 | -42.3 | -37.9 | -32.7 | -14.8 |
| EBIT margin | -494.2% | -460.0% | -225.4% | -34857.6% | -136.7% | -188.9% | | |
| Pre-tax income | -127.4 | -125.6 | -64.8 | -77.9 | -39.7 | -37.0 | -37.2 | -14.9 |
| Income taxes | 0.0 | 0.0 | 1.3 | -0.7 | -0.8 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | | 0.9% | 2.0% | 0.0% | 0.0% | 0.0% |
| Net income | -127.4 | -125.6 | -66.2 | -77.2 | -38.9 | -37.0 | -37.7 | -14.9 |
| Net margin | -479.3% | -458.9% | -231.1% | -33414.3% | -125.9% | -184.2% | | |
| |
| Diluted EPS | ($2.60) | ($2.71) | ($1.92) | ($2.98) | ($1.74) | ($2.09) | ($5.80) | ($59.32) |
| Shares outstanding (diluted) | 49.0 | 46.3 | 34.4 | 25.9 | 22.4 | 17.7 | 6.5 | 0.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|